Related Experiment Video
Updated: May 12, 2026
06:13
Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
Understanding heterogeneity in response to antidiabetes treatment: a post hoc analysis using SIDES, a subgroup
Dana S Hardin1, Rachelle D Rohwer, Bradley H Curtis
1Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA. hardin_dana_sue@lilly.com
Journal of Diabetes Science and Technology
|April 10, 2013
Summary
Younger type 2 diabetes patients with higher fasting insulin levels may benefit more from short-acting insulin. This finding explains varied treatment responses in diabetes management.
Area of Science:
- Endocrinology
- Pharmacology
- Clinical Research
Background:
- Treatment response in type 2 diabetes mellitus (T2DM) is heterogeneous due to genetic and phenotypic differences.
- Clinical trial results often rely on aggregated data, not individualized patient outcomes.
- This study utilized the SIDES algorithm to analyze treatment heterogeneity in T2DM.
Purpose of the Study:
- To assess treatment response heterogeneity in type 2 diabetes mellitus (T2DM) patients.
- To identify subgroups with differential treatment effects using the SIDES algorithm.
- To investigate individualized treatment responses beyond aggregated trial data.
Main Methods:
- Retrospective analysis of the randomized DURABLE trial involving 2091 insulin-naïve T2DM patients.
- Comparison of twice-daily insulin lispro mix 75/25 (LM75/25) versus once-daily insulin glargine.
- Application of the SIDES algorithm to identify subgroups with significantly different treatment effects on achieving glycated hemoglobin A1c (A1C) ≤7.0%.
Main Results:
- The overall treatment difference in A1C reduction was not clinically significant across the entire study population.
- A clinically meaningful difference in A1C reduction was observed in a specific subgroup.
- This subgroup comprised patients with baseline fasting insulin >11.4 μIU/ml and age ≤56 years, showing greater benefit with LM75/25.
Conclusions:
- Younger T2DM patients with higher fasting insulin levels may experience greater benefits from short-acting insulin regimens targeting postprandial glucose.
- This finding helps elucidate the heterogeneity of treatment response observed in T2DM.
- Further research is warranted to validate and explore these subgroup-specific treatment effects.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
01:03Pharmacodynamic Responses: Different Types
Pharmacodynamics is the scientific study of a drug's biochemical or physiological influence on the body. It categorizes responses into continuous, discrete (or categorical), and time-to-event outcomes. Continuous responses yield numerical values within a certain range, such as blood pressure readings and blood glucose levels, gauging the efficacy of antihypertensive and antidiabetic drugs. Discrete responses can be binary, indicating whether a drug has an effect or not, or ordinal, exemplifying...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:23Test for Homogeneity
The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can be stated as...